chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 4 yr old white female pt who on 25Feb04 was vaccinated SC with the second dose of measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot 545911/0613N). On 27Feb04, the pt developed local inflammation at the injection site. Subsequently, the pt recovered from local inflammation at the injection site (date unk). Unspecified medical attention was sought. No further information is available.
Had local rash at injection site, then after bath broke out in hives. Took over the counter antihistamine. Received a mantoux same day, same arm.
rebound Covid; rebound Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (005570).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown,single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "rebound Covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: 7 people that have got COVID again.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202200023743 PV202200023743;
Developed swollen reddened area on right arm 7/6/07 evening about 2 1/2" warm, raised, red spot. Less red this AM (7/7/07) gave Motrin.
I developed bronchitis which lasted for two weeks.  After 10 days prescription for zithromax was taken and I got better.
Approximately 4 hours after receiving the 2-month vaccinations for DTaP, Polio, Rotavirus, Pc and HIB, my child developed a high-pitched scream and could not be consoled.  He was in such pain that he could not be touched.  I called Dr. numerous times and was told the high-pitched scream was normal and was "pain from the injection site" and to "give more Tylenol."  He experienced three rounds of high-pitched screaming for 30 minutes each, separated by deep, unwakable sleep for an hour.  At no time was I advised to go to the ER or other hospital for an EEG to monitor encephalitis.
Fever 103 11/29/05 02:21 mom called consulting nurse at hospital, mom and dad gave Motrin. 6 month old with 103 degree temp, mom calling patient had 4 immunizations today, just woke up with fever, rectal temp 102, alert and active, movement of extremities times 4, took bottle, no rashes, wetting diapers, no difficult  breathing, DTP,Hib PCV, flu shot, concerned about how high fever is. For fevers > 102 F (38.9 C) give acetaminophen every 4 hours or Ibuprofen every 6 hours. Call back if fever (temperature > 100.4 F) lasts > 3 days. Pains lasts > 3 days. Caller will comply with recommended disposition.
COVID 19 Treatment; COVID 19 Treatment; Interchange of vaccine products; This is a spontaneous report received from contactable reporter(s) (Other HCP) from product quality group. The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 31Aug2022 as dose 4 (booster), single (Lot number: GJ3277) at the age of 43 years, in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 04Nov2021 as dose 3 (booster ), single (Lot number: FE3590) for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 10Jan2021 as dose 1, single (Lot number: 037K2OA) and on 07Feb2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Multiple sclerosis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment"; INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "not recovered". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (14Apr2023) Negative, notes: Tested negative on day 7 and day9; (16Apr2023) Negative, notes: Tested negative on day 7 and day9; (17Apr2023) Positive, notes: Tested positive on day 10. Therapeutic measures were taken as a result of drug ineffective, covid-19, interchange of vaccine products.; Sender's Comments: Considering interchange of vaccine, the role of company suspect drug BNT162b2 to all the reported events  DRUG INEFFECTIVE and COVID19   cannot be excluded completely as efficacy of a drug varies from patient to patient and can be affected by different factors. However the contribution of Moderna to the events cannot be excluded
This spontaneous report as received from a medical assistant (M.A.) refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 11-SEP-2015, the patient was vaccinated with the third dose of improperly stored ROTATEQ oral liquid (lot # L000571, expiration date 26-JUL-2016) (dose unspecified). No concomitant medications were reported. No adverse effects have been reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Hives and nodules to both legs per PA.  Mother states rash - right leg (Hib). Also Hive like nodule from injection site to ankle. Nodule over sight of injection DTaP. No reaction in arm (IPV). 04/27 nodules present but hives resolved.  Benadryl given.
Possible seizure activity, fever, lab work, CT scan, EEG done and hospitalization. Apnea monitor.
my daughter got very I'll; Initial information regarding an unsolicited valid non-serious case received from a non-healthcare professional (patient's mother) via social media on 26-Nov-2020.  This case involves a female patient who got very I'll (illness), after she receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, past vaccinations, family history and concomitant medications were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient got very I'll (illness), (unknown latency) following the shot of INFLUENZA VACCINE.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
General menstruation symptoms (pain, bloating, cramps) 3x worse and heavier
Noted with urticarial lesions a day following immunizations; developed accompanying low grade fever. Plus pruritus. With difficulty breathing and with swelling.
This spontaneous report as received from a registered nurse refers to a patient (age and gender not reported) who on 05-MAR-2013 was vaccinated with a dose of ZOSTAVAX, 0.65 ml, (route and lot number not reported). It was reported that the patient only received 0.5 ml dose of the product instead of 0.65 ml dose due to a PQC issue with ZOSTAVAX. No adverse experiences were reported. Additional information has been requested.
Received H1N1 in 10/16 in left arm. 30 min later she experienced numbness going down left arm to hip about 30 min later. Saw house doctor who recommended watchful waiting that day. Symptoms resolved within 15 hours. Patient then experienced neck stiffness relieved with MOTRIN on 10/19. Still has stiffness on 10/23, determined to be due to pinched nerve.
Developed hives on left forearm.  Later, on back, back of legs, thighs.
received vaccine after temperature excursion; received vaccine after temperature excursion; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (received vaccine after temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (received vaccine after temperature excursion) in a 53-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (received vaccine after temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (received vaccine after temperature excursion). In March 2021, PRODUCT TEMPERATURE EXCURSION ISSUE (received vaccine after temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (received vaccine after temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Treatment medications was not provided by the reporter
Booster; extreme joint aches and stiffness.; extreme joint aches and stiffness.; Weakness; Tiredness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 76 year-old female patient received bnt162b2 (BNT162B2), administration date 10Oct2021 (Lot number: FF2590) at the age of 76 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included High blood pressure (unspecified if ongoing). Concomitant medication(s) included LISINOPRIL taken for hypertension. Vaccination history included: Bnt162b2 (Dose: 01, lot number: EL0142), administration date: 12Jan2021, when the patient was 76 years old, for Covid-19 immunization, reaction(s) No adverse events with the first two doses; Bnt162b2 (Dose: 02, lot number: EL9264), administration date: 07Jul2021, when the patient was 76 years old, for Covid-19 immunization, reaction(s) No adverse events with the first two doses. The following information was reported IMMUNISATION (non-serious) with onset 10Oct2021, outcome unknown; ARTHRALGIA (non-serious), JOINT STIFFNESS (non-serious) all with onset 2021, outcome unknown; ASTHENIA (non-serious) with onset 2021, outcome unknown; FATIGUE (non-serious) with onset 2021, outcome unknown.  It was reported that the caller and his wife had the full series of the Pfizer Covid Vaccine and the booster dose. They had no adverse events with the first two doses but had many side effects with the booster dose. The caller wanted information about the temp tales, he wanted information on the device that monitors the temperature of the shipper the Pfizer Covid Vaccine is shipped in. The joint aches and stiffness started a few days later. They are both very active and walk 5 to 6 miles per day. They have always been very agile. It is really striking to them that they feel weak and tired. She is basically a healthy person. At her age she went to the cardiologist as a precaution. Follow-up attempts are completed. No further information is expected.  No follow-up attempts are possible. No further information is expected.
Received vaccination Friday morning, at around 10pm she started having a twitch in her face and limbs, then her lips turned blue, then her whole face turned blue and her limbs were white and motionless. This lasted a couple of min then she gasped for air for 30 sec, then she returned to normal. No prodromal signs or symptoms.
Called health system call center to report ab cramping after receviing 1st dose of vaccine. Pt noted having ad cramping the previous day prior to receiving maccine. She also reports - palpitations chills, headachs, dizziness, and pain at injection site.  Pt was advised to go ED for additinal evaluation
Pt admitted on 04/05/20 with SOB and altered mental status. Was given steroids and supportive care throughout admission and transitioned to comfort care on 04/09/2021 and passed away the next day.   Patient had received both doses of COVID vaccine and tested positive for COVID 41 days later
Data exchange not properly working in EHR. Office procedure did not include reconciliation of vaccines. Causing extra dose to be given.
Extreme body aches as well as injection site/ headache/ low grade temp   Oral ibuprofen was taken and eased symptoms. By 1 pm on 1/28/21, extreme fatigue set in followed by 12 hours of sleep.  On 1/29/21, symptoms were subsiding and left arm pain was diminished.
fever, swollen Arm, Redness on Arm (left) where pneumovax was administered.
Itchy throat, red band around the arm where the shot was given, redness from elbow to shoulder. Had to take prednisone and Keflex.
08/24/2020 started feeling  weakness in my legs. Beginning  in September I stared getting tingling in my feet and hands. My doctor began monitoring my symptoms. The symptoms continued to get worse. I went to emergency room 10/18/2020 since I was having  difficulty walking.  They did a lumbar puncture and MRI and diagnosed Guillain Barre. I was admitted to the hospital and received IVIG treatment for 5 days. I started to improve but then plateaued . I started relapsing in December and was put on 60mg of prednisone. 01/07/2021 I saw Dr. (neurologist) who diagnosed CIDP. There was some improvement. 02/22/2021 had an IVIG treatment again .  My symptoms started improving. 03/04 2021 had Nerve test which revealed demylelination.
Information has been received from an office manager via a company representative referring to a 73 year old female patient. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were unknown by reporter. On 31-OCT-2018, the patient received an injection of PNEUMOVAX 23 (intramuscular, 1 x 0.5 mL dose; strength, batch/lot # and expiration date were not reported) for prophylaxis (reported as prevention of pneumonia). On the same date, the patient experienced cellulitis on her right arm and her arm was warm to the touch from below the deltoid to below the elbow. At the time of report, the patient had recovered from the events. The treatment was given for the events. The patient had sought medical attention. Information about lab diagnostics/studies was unknown by reporter.The causality was not reported. Upon internal review, the event of cellulitis of arm was determined to be medically significant.
Initial information received on 22-Jun-2018 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 15 months old patient who experienced 4th dose of this was given in error 1.5 months from the last dose, while he/she received vaccines ACT-HIB and IPOL. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect HIB (PRP/T) VACCINE lot number not reported via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect IPV (VERO) lot number not reported via unknown route in unknown administration site. The patient developed a non-serious 4th dose of this was given in error 1.5 months from the last dose <<Unknown latency>> following the administration of IPV (VERO) and <<Unknown latency>> following the administration of HIB (PRP/T) VACCINE. Final diagnosis was 4th dose of this was given in error 1.5 months from the last dose. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Not Applicable for 4th dose of this was given in error 1.5 months from the last dose.
Pt was seen on 9-6-2011 for vaccine immunizations. 9-8-11 returned to clinic with c/o redness, swelling & pain Lt upper arm that started 9/6 & had increased on 9/7. Pt has no SOB, difficulty swallowing, or itching. Upper arm is swollen & erythematous & warm to touch. Pt has a pacemaker in place & is on cardiac meds. Referred to her PCP for further evaluation. Pt to call back with Dr.'s recommendation.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 19-Jul-2022; No adverse event; Administered the vaccine after the 30 day by use date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day by use date), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 19-Jul-2022) and NO ADVERSE EVENT (No adverse event) in an 84-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day by use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 19-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day by use date), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 19-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day by use date) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 19-Jul-2022).    No concomitant medications were reported.   The patient received half dose. The vial did not undergo any temperature excursions.  No treatment details were reported.
When administering the booster for moderna some of the vaccine dripped out so the full dose was not recieved
Soreness in arm / shoulder (where shot administered), Bad headache around ~2:30. Shivers ~1 AM.
Localized swelling, erythema & warmth the size of a half-dollar are reported in a pt who recvd flu vax; rxn lasted 5 days;
appendicitis and was rushed to the hospital where she had to undergo emergency surgery; This is a spontaneous report from a contactable consumer (patient). A 23-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot Number: ewo186), via an unspecified route of administration on 11Jun2021 (at the age of 23-year-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient was not pregnant at time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient stated exactly one week after receiving her first dose of the vaccine on 19Jun2021, she had appendicitis and was rushed to the hospital where she had to undergo emergency surgery. The event resulted in doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient considered the event as serious as it was life-threatening, caused/prolonged hospitalization (hospitalized for 2 days) and Disabling/Incapacitating. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of appendicitis was surgery. The event outcome was recovering.  Follow-up attempts are completed. No further information is expected.
Redness, itchy and tenderness at site of injection. Injection given on Sunday 2/2/2019 patient noticed small reaction but didn't think much of it. On Tuesday 02/05/2019, patient had surgery and nurse noted red area on arm.
Wife states that the patient woke up this morning around 3:30, extremely dizzy and nauseous. She noted that he has been running a fever, but did not have a reading. He has vomited and has not been able to keep down solid food. He has also experienced diarrhea.
Information has been received from a nurse concerning a 16 year old female with no medical history of drug allergy who on 11-JUL-2008 was vaccinated with the first dose of GARDASIL (lot # 660557/0072X). 0.5ml, IM in her arm. Concomitant therapy included hormonal contraceptives (unspecified). On 11-JUL-2008 the patient experienced pain. The patient was a gymnast and the pain interfered with her performance at a competition the following day. The second dose was administered on 12-SEP-2008 in her gluteal muscle at the patient's request. The patient did not perform any lab diagnostics studies. At time of report the patient recovered. The patient did not seek medical attention. Follow-up information has been received from a nurse concerning the patient who received the third dose of GARDASIL in the arm on 15-JAN-2009. Subsequently the patient experienced soreness. At time of the report the outcome of the patient was unknown. The patient sought unspecified medical attention. This is one of several reports from the same source. Additional information has been requested.
RASH ON MY UPPER CHEAST AND NECK AND UPPER ARMS.  SCRATCHING AND RED BUMPS
Child developed a rash at the injection site. Reported it to me, the school nurse, the day after receiving her vaccine. Says that she did notice it yesterday evening as well. Area is red, warm, and slightly raised. Area affected is approx. 4 in by 3 in. No itching or systemic reaction. Area is sore. No other symptoms.
This case was reported by a healthcare professional via sales representative and described the occurrence of injection site redness in a male subject of unspecified age who was vaccinated with FLUARIX Quadrivalent (GlaxoSmithKline). On an unspecified date in 2013 the subject received unspecified dose of FLUARIX Quadrivalent (.5 ml, unknown, unknown arm). In 2013, within months after vaccination with FLUARIX Quadrivalent, the subject experienced enlarged injection site, injection site redness and patchiness at injection site" details were not provided. The subject was vaccinated on an unspecified date but returned to the physician's office in October 2013 for treatment. The subject was treated with BENADRYL. At the time of reporting the outcome of the events were unspecified.
On 03/10/2021 bad headache, fever, leg arm went numb . Headache lasted for three days, other symptoms went away after 24 hours. I had several A-VIB events in the 24 hours, and went into kidney failure, and was hospital for three days. The Thyroid, Cholesterol  and  kidney failure.
1st shot: left arm immobilized first 24 hours, stiff neck for 24-48 hours, pain and sensitivity on back of head 48 hours, lethargy 72 hours. 2nd shot: stiff neck, lethargy, pain and sensitivity on back of head; most notably extreme/violent uncontrollable full-body shiver episode to the point of cramping in ribs, muscle spasming, goosebumps, feeling cold and clammy. This occurred a few min after a warm shower and upon entering bed for sleep. Preceding episode my skin felt sensitive to the touch, to the point it was uncomfortable to use a wash poof during shower. The episode lasted at its highest intensity for 2-3 min, after peak it lasted for 20 min total. I was unable to get up during the peak to grab warm clothing or a blanket. I had no control over my body mobility.